6. Treatment Options and Individualized Care

To understand the treatment options available and be able to discuss them appropriately to provide individualised patient care


Full content only available after log-in


6.1.  Knows the different treatment modalities for IBD taking into account disease extent, activity, previous history and complications

6.2.  Knows the modes of delivery of different drug therapies and their advantages and disadvantages

6.3.  Recognises the importance of patient choice in deciding therapy and in helping to ensure adherence

6.4.  Understands the evidence base behind different therapeutic strategies and when they might be appropriate (conventional step care, optimised step up, top down and treat to target)

6.5.  Appreciates the monitoring requirements for specific therapies

6.6.  Appreciates common side effects and complications of therapy, their frequency and how to manage them

6.7.  Appreciates the importance of on-going disease monitoring to confirm efficacy

6.8.  Understands when surgery is the most appropriate therapeutic option

6.9.  Is up to date with the evidence base from current clinical trial and real world data sets for the use of available therapies

6.10.  Has knowledge of the role of optimising therapy including interpretation of therapeutic drug monitoring for conventional and biological therapies

6.11.  Appreciates the role of stopping medical therapies in IBD and the appropriate timing / patient population in whom drugs can be stopped


        
 
Topic:











Programme Phase:



Content Format:








Page: () 1 2 3 4 5 6 7 8 ()

Topic 6.2, 6.5 :

Save the patient Medical treatments

P. Hindryckx

ECCO'18 Vienna

Webcast + PPT
 


Topic 6.2, 6.6 :

Managing complications associated with anti-TNF therapy

S. Ben-Horin

ECCO'18 Vienna

PPT
 


Topic 6.3 :

Medication adherence, worries and concerns in IBD

S. Jghult

ECCO'18 Vienna

PPT
 


Topic 6.3 :

Patient perspective on treatment goals

C. Siegel

ECCO'18 Vienna

Webcast + PPT
 


Topic 6.3 :

Probiotics and Ulcerative Colitis

A. Hart

ECCO'18 Vienna

PPT
 


Topic 6.3 :

What are risk factors for complicated IBD outcome?

K. Gecse

ECCO'18 Vienna

PPT
 


Topic 6.4 :

Nursing roles in IBD management

L. Moortgat

ECCO'18 Vienna

Webcast + PPT
 


Topic 6.4, 6.5 :

Targeting early disease - lessons from rheumatoid arthritis

D. Aletaha

ECCO'18 Vienna

Webcast + PPT
 


Topic 6.4, 6.6, 6.9 :

Enhanced postoperative recovery pathways

G. Fiorino

ECCO'18 Vienna

Webcast + PPT
 


Topic 6.5 :

What are risk factors for complicated IBD outcome?

K. Gecse

ECCO'18 Vienna

PPT
 


Page: () 1 2 3 4 5 6 7 8 ()